Neoleukin: Q1 Earnings Snapshot

SEATTLE (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Wednesday reported a loss of $15 million in its first quarter.

The Seattle-based company said it had a loss of 27 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

Neoleukin shares have decreased 19% since the beginning of the year. The stock has declined 14% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NLTX at

The Associated Press